Characteristics of Women With a Diagnosis of Breast Cancer (N=105,105)
Characteristic | Value |
---|---|
Total ambulatory primary care physician visits, n (%) | |
0–1 | 21,469 (20.4) |
2–4 | 19,355 (18.4) |
5–10 | 33,364 (31.7) |
≥11 | 30,917 (29.4) |
Total ambulatory non–primary care physician visits, n (%) | |
0–1 | 39,031 (37.1) |
2–4 | 23,308 (22.2) |
5–10 | 23,230 (22.1) |
≥11 | 19,536 (18.6) |
Age at diagnosis, y (%) | |
67–75 | 51,290 (48.8) |
76–85 | 42,913 (40.83) |
≥86 | 10,902 (10.37) |
Race/ethnicity, n (%) | |
White, non-Hispanic | 90,372 (86.0) |
Black, non-Hispanic | 6,694 (6.4) |
Hispanic | 3,931 (3.7) |
Asian/American Indian/Pacific Islander | 3,425 (3.3) |
Other | 683 (0.7) |
Marital status, n (%) | |
Single (never married) | 7,564 (7.2) |
Married | 43,030 (40.9) |
Separated/divorced | 6,913 (6.6) |
Widowed | 43,280 (41.2) |
Unknown | 4,318 (4.1) |
MSA of residence, n (%) | |
Large metropolitan | 60,122 (57.2) |
Metropolitan | 29,272 (27.9) |
Urban | 6,360 (6.1) |
Less urban | 7,632 (7.3) |
Rural | 1,714 (1.6) |
Year of diagnosis, n (%) | |
1994–1997 | 24,139 (23.0) |
1998–2000 | 23,597 (22.5) |
2001–2005 | 57,369 (54.6) |
Histologic type, n (%) | |
Ductal | 74,760 (71.1) |
Lobular | 17,176 (16.3) |
Ductal/lobular | 347 (0.3) |
Favorable | 5,961 (5.7) |
Unfavorable | 1,315 (1.3) |
Undefined | 5,546 (5.3) |
Estrogen receptors, n (%) | |
Positive/borderline | 49,010 (46.6) |
Negative | 9,147 (8.7) |
Missing | 46,948 (44.7) |
Progesterone receptor, n (%) | |
Positive/borderline | 40,265 (38.3) |
Negative | 17,027 (16.2) |
Missing | 47,813 (45.5 |
Tumor size, mm | |
Mean (SD) | 20.2 (20.6) |
Median (minimum-maximum) | 15 (0–990) |
AJCC stage at diagnosis, n (%) | |
0 (in situ) | 14,568 (13.9) |
I | 42,830 (40.8) |
II | 27,602 (26.3) |
III | 6,012 (5.7) |
IV | 3,399 (3.2) |
Unknown | 10,694 (10.2) |
Charlson comorbidity index, n (%)a | |
0 | 61,466 (58.5) |
1 | 24,979 (23.8) |
≥2 | 18,660 (17.8) |
Influenza vaccination, n (%) | |
No | 46,673 (44.4) |
Yes | 58,432 (55.6) |
AJCC = American Joint Commission on Cancer; MSA = metropolitan statistical area.
↵a Scored on a range from 3–35, where higher scores indicate increased morbidity.